1 / 2

Renal Denervation Industry Research Report - Global Forecast till 2023

Renal Denervation Industry Research Report - Global Forecast till 2023

Rohitravan
Télécharger la présentation

Renal Denervation Industry Research Report - Global Forecast till 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Renal Denervation Industry by Product (Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis, Others), by Technology (Radiofrequency, Ultrasound, Micro-infusion, and Others), by End-user (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Region - Forecast To 2023. Market Scenario Renal Denervation Industry is expected to rise at a solid CAGR of 40.4% over the 2018-2023 forecast period, according to a new research report from Market Research Future (MRFR). The market’s value is expected to rise from USD 200 million in 2017 to USD 2,850 million in 2023. Avail Sample Research@ https://www.marketresearchfuture.com/sample_request/6712 Renal Denervation Industry is expected to be driven mainly by the rising prevalence of hypertension around the world. Hypertension has been one of the main beneficiaries of the modern lifestyles and dietary patterns, and has grown in prevalence steadily over the last decade and more. Key Players Leading players in the global Renal Denervation Industry include Boston Scientific, Medtronic, ReCor Medical, St. Jude Medical, Cardiosonic, Cordis, Kona Medical, Sound Intervention, and Terumo. Renal Denervation Industry is hamstrung by challenging government regulations in regions such as the U.S. Medtronic recently announced the launch of a new placebo-controlled randomized clinical trial in an effort to get regulatory approval in the U.S., a major commercial market for high blood pressure remedies. Segmentation The global Renal Denervation Industry is segmented on the basis of product, technology, and end use. By product, the Renal Denervation Industry is segmented into Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis, and others. Symplicity holds the largest market share in the Renal Denervation Industry at present and is likely to remain a leading contributor over the forecast period. However, Paradise is likely to be the fastest growing product segment in the Renal Denervation Industry over the forecast period. On the basis of technology, the global Renal Denervation Industry is divided into radiofrequency, ultrasound, micro-infusion, and others. Radiofrequency is likely to be the fastest growing segment over the forecast period, eclipsing ultrasound, the largest market segment at present, in terms of growth rate. By end user, the Renal Denervation Industry is segmented into hospitals, clinics, ambulatory surgical centers, and others. Hospitals are the largest segment in the global Renal Denervation Industry, while ambulatory surgical centers are expected to exhibit the fastest growth over the forecast period. Regional Analysis By region, the global Renal Denervation Industry is segmented into North America, Europe, Asia Pacific (APAC), and Rest of the world. Europe is likely to dominate the global Renal Denervation Industry over the forecast period due to the strong research infrastructure in the region and the increasing development of progressively more Market Research Future Magarpatta Road, Hadapsar, Pune

  2. advanced renal denervation devices. The increasing prevalence of drug-resistant hypertension in Europe is further likely to drive research in the Renal Denervation Industry, ensuring Europe’s dominance in the Renal Denervation Industry over the forecast period. Asia Pacific is also likely to be a major regional market for renal denervation over the forecast period due to the growing prevalence of hypertension and the steady improvement in healthcare infrastructure. This is likely to ensure widespread availability of renal denervation devices as well as increasing research into product development to produce more advanced renal denervation devices over the forecast period. Brows denervation-market-6712 Complete Research Report@ https://www.marketresearchfuture.com/reports/renal- Research Methodology MRFR leverages its in-house expertise for drawing insightful conclusions into the market. Extensive primary and secondary research are undertaken which include SEC filings, interviews with stakeholders across the value chain, whitepaper references, etc. for backing the research findings. Top-down and bottom-up approaches employed validate the authenticity of the statistical observations available in the report. Furthermore, a multi-layer verification process is applied for eliminating deviations and discrepancies. About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future Magarpatta Road, Hadapsar, Pune

More Related